中文
English
한국어
日本語
Español
Français
Русский
| 카탈로그 번호 | HB996046 |
|---|---|
| 설명 |
Blinatumomab (HB996046) is a research-grade recombinant antibody targeting CD19. Produced in mammalian cells with native-like glycosylation.
Highlights
|
| 종 반응성 | Human |
| 응용 분야 | ELISA, Bioactivity: FCM, Functional assay, Research in vivo |
| 숙주 종 | Mouse |
| 클론성 | Monoclonal |
| 이소타입 | (scFv-kappa-heavy)-(scFv-heavy-kappa) |
| 타겟 | B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, CD19, Differentiation antigen CD19, T-cell surface antigen Leu-12, CD3E, CD3e, T-cell surface antigen T3/Leu-4 epsilon chain, T-cell surface glycoprotein CD3 epsilon chain, T3E |
| 내독소 수준 | < 10 EU/mg |
| 순도 | >95% as determined by SDS-PAGE. |
| 정제 | Purified by Nickel column. |
| 등록번호 | P15391 & P07766 |
| 형태 | Liquid |
| 저장 완충액 | 30 mM Histidine, pH5.8, 10% sucrose, 0.02% Tween80 데이터시트 인쇄본 또는 로트별 COA에 기재된 구체적인 완충액 정보를 참조하세요. |
| 안정성 및 저장 | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| 대체 이름 | Bispecific, CD19, AMG103, BITEMT-103, MEDI-538, MT103, bscCD19xCD3, 853426-35-4 |
| 배경 | Blinatumomab (Anatumomab) is a bispecific monoclonal antibody with two binding sites, one for CD3E on T cells and one for CD19 on B cells. Blinatumomab can be used in research for acute lymphoblastic leukemia. |
| 참고사항 | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype Control | BiTE Format Isotype Control for Bispecific Reference Antibody (HP473013) |
SDS-PAGE for Anti-Human CD19 & CD3 epsilon Bispecific Reference Antibody (Blinatumomab, RUO)
SEC-HPLC detection for Research Grade Blinatumomab.
+86-027-65523339
중국 우한시 심둔사로 666번지 C동, 우한, 430206
